• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

CHIPS Trial Comparing Cold and Room-Temperature Stored Platelets for Cardiac Surgery Patients

August 26, 2026

Over 50 years ago room-temperature stored platelets (RTPs) were shown to have increased platelet recovery and survival compared to cold-stored platelets (CSPs). However, about 10-20% of RTPs are outdated and wasted due to the short storage time. In 2023, the U.S. FDA approved CSPs up to 14 days to treat bleeding patients when RTPs are not feasible, but questions still remain about the hemostatic effectiveness of CSPs. The Chilled Platelet Study (CHIPS) was a phase 3 partially blinded noninferiority trial to compare CSPs stored up to 21 days to RTPs in patients at risk of bleeding undergoing cardiac bypass surgery; 1181 patients (mean age, 42 years; 68% male) were randomized 2:1 to receive either CSPs or RTPs at 27 hospitals in the U.S. and Australia. During the study, 650 patients were transfused CSPs and 339 standard RTPs. The primary outcome of hemostatic efficacy (a 5-point scale adapted from the universal perioperative bleeding score) was similar in both study arms—3.08 (95% C.I., 2.99 to 3.17) and 2.99 (95% C.I., 2.88 to 3.11) in the CSP and RTP arms, respectively. This suggests that CSPs may be hemostatically as effective as RTPs in cardiac surgery patients. However, re-exploration rates for bleeding and total volume of blood per kg transfused were higher for the CSP arm than for the RTP arm, and viscoelastic clot stiffness measures were lower in the group receiving CSPs. While CSPs may be useful for some patients, especially in locations where RTPs are not feasible to keep in inventory, more research is needed for other patient subgroups.

References:

  1. Spinella PC, Zantek ND, VanBuren JM, Nicolson SC, et al; CHIPS Investigator Group. Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial. JAMA. 2026 Aug 17:e2613328. doi: 10.1001/jama.2026.13328. Epub ahead of print. PMID: 42606886; PMCID: PMC13482631.  
  2. Hess AS. A World With Platelets Stored Cold for 21 Days: Chill and Tender. JAMA. 2026 Aug 17. doi: 10.1001/jama.2026.13885. Epub ahead of print. PMID: 42606881.
  3. Estrera AL, Miller CC 3rd. A New Era for Cold-Stored Platelets in Cardiac Surgery. JAMA Surg. 2026 Aug 17. doi: 10.1001/jamasurg.2026.3888. Epub ahead of print. PMID: 42606878.
  4. Cold and Room-Temperature Platelets in Cardiac Surgery: Research Summary. JAMA. 2026 Aug 17:e2613621. doi: 10.1001/jama.2026.13621. Epub ahead of print. PMID: 42606875.

Filed Under

  • News
  • Platelet Transfusion

Recommended

  • Frequent Platelet Donors at Risk for Lymphopenia

  • Donor-Specific Antibody Levels and Platelet Transfusion Response Among Refractory Patients

  • Convalescent Plasma for COVID-19 Safe in First 5,000 Patients

Show Comments

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Alpha-Gal Syndrome as a Potential Cause of Allergic Transfusion Reactions

  • Emerging Transfusion Transmitted Infections

  • CHIPS Trial Comparing Cold and Room-Temperature Stored Platelets for Cardiac Surgery Patients

  • Neonatal Platelets Limit Adaptive Immune Response

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley